أخبار

  1. Aug. 21, 2021

    Patients with history of pelvic radiation can receive revision surgery for artificial urinary sphincter

    Researchers found no significant difference in outcomes between patients with and patients without a history of radiation who received revision of an artificial urinary sphincter (AUS).

  2. Aug. 21, 2021

    High-intensity focused ultrasound for the treatment of prostate cancer

    High-intensity focused ultrasound (HIFU) allows specialists to treat only the area of the most aggressive tumor while leaving the rest of the prostate and its surrounding structures alone.

  3. Aug. 21, 2021

    Simplified patient dismissal instructions improve patient experience following robot-assisted radical prostatectomy

    Patients who received more-understandable dismissal instructions following robot-assisted radical prostatectomy were significantly less likely to call with clarifying questions or have an emergency department visit.

  4. May 22, 2021

    Study assesses cost-effectiveness of pembrolizumab for treatment of bacillus Calmette-Guerin-unresponsive bladder carcinoma in situ

    Research confirms that pembrolizumab at current pricing is not cost-effective for patients with bladder cancer that has proved unresponsive to bacillus Calmette-Guerin (BCG) treatment.

  5. May 22, 2021

    National patterns of filled prescriptions and third line treatment use for privately insured women with overactive bladder

    Referral to specialists may close a gap in care for women who do not have success with oral therapies for overactive bladder.

  6. May 22, 2021

    Development of urosymphyseal fistula in posterior urethral stenosis

    Research supports that patients who develop posterior urethral stenosis and urosymphyseal fistula following salvage radiation after prostatectomy can achieve a durable restoration of quality of life.

  7. Feb. 05, 2021

    Hydronephrosis and bladder cancer

    Retrospective research does not support an increased risk of upper tract urothelial carcinoma (UTUC) in patients receiving preoperative ureteral stenting for hydronephrosis requiring drainage prior to cystectomy.

  8. Feb. 05, 2021

    Ureteral injury malpractice compensation highest in cases of patient-perceived delays, inadequate workup and failure of supervision

    Multiple studies suggest that iatrogenic ureteral injuries, while uncommon, make up a disproportionate number of litigation claims. Gynecology and urology are the specialties most commonly named.

  9. Feb. 05, 2021

    High-risk nonmuscle invasive bladder cancer

    In a phase III clinical trial, 53% of patients with nonmuscle invasive bladder cancer (NMIBC) in the carcinoma in situ cohort had a complete response within three months of treatment.

  10. Nov. 20, 2020

    COVID-19 adjustments impact Urology Residency training

    Boyd R. Viers, M.D., associate program director of the Urology Residency program at Mayo Clinic in Rochester, Minnesota, discusses pandemic-related changes in the program.

  11. Nov. 20, 2020

    Men's Health moves many operative procedures into the office

    Mayo Clinic's Men's Health specialists now perform testicular sperm extraction, circumcision, scrotoplasty, orchiopexy, hydrocelectomy, and spermatocelectomy or epididymal cyst excision and epididymectomy in-office, wit[...]

  12. Nov. 20, 2020

    Therapeutic sequencing improves outcomes for patients with progressive mCRPC

    Researchers investigated the long-term oncologic outcomes of three chemotherapy regimens in patients who had previously experienced disease progression after treatment with a novel androgen receptor inhibitor.

  13. Sept. 15, 2020

    New research indicates maintenance bacillus Calmette-Guerin is not cost-effective for all patients with intermediate- and high-risk nonmuscle invasive bladder cancer

    New research supports prioritizing bacillus Calmette-Guerin (BCG) for induction therapy during shortages and reserving maintenance BCG for patients at the highest risk of progression.

  14. Sept. 15, 2020

    Standardized postoperative opioid prescribing significantly reduces use following urologic surgery

    Prescribing patterns four months after guideline implementation were reduced to a median quantity of 100 OME (roughly 13 5 mg oxycodone tablets) compared with 150 OME before implementation.

  15. Sept. 15, 2020

    Integrating telemedicine into the Mayo Clinic Urology practice to expand options for patients

    The COVID-19 pandemic provided opportunities to explore telemedicine consults with adult and pediatric urology patients.

  16. Feb. 22, 2020

    Percutaneous biopsy of suspicious upper tract lesions a safe diagnostic strategy

    A retrospective review of patients who received percutaneous image-guided core-needle biopsy for diagnosis of upper tact urothelial carcinoma supports that the process is safe and well tolerated by those patients.

  17. Feb. 22, 2020

    Mayo Clinic's approach to Peyronie's disease: Nonsurgical interventions

    Mayo specialists consider three key points when determining optimal treatments for patients with Peyronie's disease: baseline erectile function, duration of symptoms and level of invasiveness the patient will consider.

  18. Feb. 22, 2020

    Optimal sequencing of commonly used medications for treatment of metastatic castration-resistant prostate cancer

    Research supports the use of docetaxel before enzalutamide or abiraterone as the primary first line therapy for metastatic castration-resistant prostate cancer.

  19. Dec. 10, 2019

    Scientists find autoimmune disease related to testicular cancer

    Scientists urge screening for paraneoplastic encephalitis autoimmune disease in patients with testicular cancer: Mayo Clinic Forefront cancer magazine.

  20. Nov. 05, 2019

    Pediatric rhabdomyosarcoma: Research and new treatment options

    A new trial of adjuvant surgical treatment with hyperthermic intraperitoneal chemotherapy (HIPEC) specifically addresses pediatric patients with relapsed intra-abdominal and pelvic rhabdomyosarcoma.

  21. Nov. 05, 2019

    Adjuvant radiation for patients with positive margins after prostatectomy decreases local recurrence; no difference in overall survival

    Research indicates adjuvant radiation for patients with positive surgical margins after prostatectomy decreases local recurrence with no difference in overall survival.

  22. Nov. 05, 2019

    Ultrasound-guided transperineal prostate biopsy

    Mayo Clinic specialists perform transperineal biopsy, which helps to accurately diagnose prostate cancer in patients with lesions or past complications and limits the infectious complications associated with transrectal[...]

  23. Aug. 27, 2019

    Artificial urinary sphincter placement: Innovations and practices

    Mayo Clinic's minimal-touch protocol for artificial urinary sphincter placement minimizes perineal and abdominal skin exposure to decrease the rate of device infection.

  24. Aug. 27, 2019

    Idiopathic chronic scrotal content pain: Q and A with Matt Ziegelmann, M.D.

    There are no standardized guidelines for evaluation and management of chronic scrotal content pain, but a consistent algorithm for evaluation and management can improve patients' quality of life.

  25. Aug. 27, 2019

    New analysis shows radical prostatectomy to be cost-effective management of prostate cancer

    A cost-effectiveness study indicates that the ProtecT trial actually supports the upfront treatment of more-aggressive prostate cancers and the surveillance of less aggressive prostate cancers.

  26. June 21, 2019

    Pushing the envelope of robotic urologic surgery in children

    A single-port robotic system offers a safe, efficacious approach for minimally invasive surgeries, including pyeloplasty and appendicovesicostomy, in pediatric patients.

  27. June 21, 2019

    Redefining the male urethral stricture treatment paradigm

    With Mayo Clinic's outpatient same-day ambulatory surgery approach, 95% of men treated for urethral stricture disease report a high level of patient satisfaction, with no difference in reconstructive outcomes.

  28. June 21, 2019

    New data indicate percutaneous ablation may be an appropriate option for certain patients with renal masses

    A review of patients treated with partial nephrectomy, percutaneous radiofrequency ablation or percutaneous cryoablation for small renal masses found no clinical or statistical difference in five-year outcomes.

  29. May 09, 2019

    A novel risk score may help urologists determine which patients with kidney stones require urgent intervention

    Researchers identified four significant predictors of infection to create a novel risk score that may help confirm which patients require urgent decompression via ureteral stent or nephrostomy tube placement.

  30. April 23, 2019

    Mayo Clinic offers comprehensive care for women with pelvic floor disorders such as pelvic organ prolapse and urinary incontinence

    Mayo Clinic's unique, multidisciplinary approach to managing sensitive female pelvic floor disorders allows for individualized decision-making and broad access to a multitude of treatment options.

  31. April 23, 2019

    Choice of intraoperative irrigation matters for penile implants: Povidone-iodine leads to a ninefold increase in the likelihood of developing an infection

    A switch from use of undiluted povidone-iodine to vancomycin-gentamicin for intraoperative irrigation reduced postoperative prosthesis infections by a factor of nine.

  32. Feb. 20, 2019

    Mayo Clinic experience with da Vinci SP single-port robot-assisted radical prostatectomy

    Mayo specialists have performed more than 40 prostatectomies using the da Vinci SP single-port robot-assisted surgical system. They report unique benefits and favorable outcomes.

  33. Feb. 19, 2019

    Boyd R. Viers, M.D., specializes in reconstructive genitourinary surgeries

    Dr. Viers specializes in advanced urinary reconstruction for radiation, trauma and iatrogenic urinary tract injury, and management of urinary obstructions including male urethral stricture disease, ureteral stricture an[...]

  34. Feb. 19, 2019

    Top-of-the-line treatment for Wilms' tumor

    Mayo Clinic's Fertility Preservation Program, 3D modeling, minimally invasive surgery techniques and proton beam therapy improve survival rates for children with Wilms' tumor.

  35. Feb. 19, 2019

    New studies of renal masses may assist in patient counseling

    Study findings expand providers' abilities to better educate patients with small renal masses and provide context for management strategies, enabling more-informed decisions about treatment options.

  36. Dec. 21, 2018

    Beating the beast: Mayo Clinic's pediatric urologists and their sarcoma team's mission to cure rhabdomyosarcoma

    Mayo pediatric radiologists construct 3D, color-coded models of the tumor and surrounding structures to assess the best potential therapies for each child and assist the surgical team with preoperative planning and refe[...]

  37. Dec. 21, 2018

    Minimally invasive focal therapies for prostate cancer

    Focal therapy treats only the area with the most aggressive tumor, while leaving the rest of the prostate and its surrounding structures alone. Available options include cryoablation, focal laser ablation and high-frequ[...]

  38. Dec. 20, 2018

    Brian J. Linder, M.D., female pelvic medicine and reconstructive surgery specialist, joins Mayo Clinic Urology

    Brian J. Linder, M.D., a specialist in the management of overactive bladder, including advanced treatment options such as bladder Botox injection, sacral neuromodulation and noninvasive percutaneous tibial nerve stimula[...]

  39. Variation in postoperative opioid prescribing provides motivation for a more standardized approach

    Variation in postoperative opioid prescribing provides motivation for a more standardized approach